Abstract
Administration of varying doses (10-50 micrograms) of deglycosylated human CG (DG-hCG) which was previously shown to be a potent hormonal antagonist in vitro, to pregnant rats inhibited implantation and terminated gestation. When administered between days 1-5 implantation was inhibited as seen on day 10. Serum progesterone levels were also suppressed. Similar doses administered between days 8 and 11 resulted in complete fetal resorption when examined on day 16. This was also accompanied by a dramatic reduction in serum progesterone. A dose of 50 micrograms DG-hCG given during the second half of pregnancy between days 13 and 16 had no deleterious effect on pregnancy including the day of parturition but the number of pups delivered was reduced by 26% as compared to 3% loss in control groups. It is concluded that DG-hCG can successfully antagonize hormone action in vivo by blockade of ovarian receptor sites for LH in the pregnant rat.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
